abilify maintena 300 mg
lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 300 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
abilify maintena 300 mg
lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 300 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
abilify maintena 400 mg
lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
abilify maintena 400 mg
lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
abilify maintena 400 mg
lundbeck israel ltd - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
abilify tablet 10 mg
otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - tablet - 10.0 mg - aripiprazole 10.0 mg
abilify tablet 5 mg
otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - tablet - 5.0 mg - aripiprazole 5.0 mg
abilify 10mg tab.
otsuka pharmaceutical-japan - tablet - 10 mg
abilify 10mg discmelt orally disintegrating tab.
otsuka egypt - disintegrating tablet - 10 mg
abilify maintena aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial
lundbeck australia pty ltd - aripiprazole, quantity: 400 mg (equivalent: aripiprazole monohydrate, qty 416.07 mg) - injection, diluent for - excipient ingredients: water for injections - for the acute and maintenance treatment of schizophrenia in adults. for maintenance treatment to prevent the recurrence of manic or mixed episodes of bipolar i disorder in adult patients as monotherapy.